US CDC Panel Moves To Simplify Pfizer/BioNTech, Moderna COVID-19 Vaccine Booster Recommendations

Citing considerations of simplification, implementation and equity, Advisory Committee on Immunization Practices says everyone ages ≥50 years should get an mRNA vaccine booster dose and recommends all individuals ≥18 years have the option of getting one, without regard to occupational exposure or underlying medical conditions.

Simplify concept
Simplifying COVID-19 booster recommendations was a priority for many ACIP members. • Source: Alamy

With the US Food and Drug Administration’s newly broadened emergency use authorization for the Pfizer Inc./BioNTech SE and Moderna, Inc. COVID-19 vaccines in hand, a Centers for Disease Control and Prevention panel voted on 19 November to expand recommended use of the mRNA vaccine booster doses and simplify determinations for eligibility.

The Advisory Committee on Immunization Practices recommended extending the option to get a single booster dose to all individuals ages 18 years and older. In a separate vote, the committee...

More from Vaccines

More from Pink Sheet